tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Dogwood Therapeutics Inc

DWTX
Add to Watchlist
1.640USD
+0.060+3.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
54.78MMarket Cap
LossP/E TTM

Dogwood Therapeutics Inc

1.640
+0.060+3.80%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

DWTX Financials

See Dogwood Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Dogwood Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
--/-0.26
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-7.13
45.18%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
98.41%-0.15
95.88%-0.26
84.03%-8.20
-73.84%-1.99
-456.13%-9.32
-338.58%-6.28
-3075.76%-51.35
41.43%-1.15
18.97%-1.68
68.99%-1.43
---1.62
---1.96
---2.07
---4.62
----
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
62.89%-4.99M
54.13%-3.78M
-590.35%-15.74M
-262.66%-3.81M
-940.65%-13.44M
-647.12%-8.24M
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
46.04%-1.10M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
-29.59%-3.96M
30.61%-4.51M
-50.88%-4.11M
-554.30%-4.28M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-14.59%-5.08M
49.53%-3.81M
-587.00%-15.81M
-266.71%-3.92M
-237.11%-4.43M
-562.68%-7.54M
-80.58%-2.30M
27.58%-1.07M
15.62%-1.31M
45.54%-1.14M
50.84%-1.27M
59.77%-1.48M
60.69%-1.56M
50.10%-2.09M
36.95%-2.59M
14.29%-3.67M
-29.56%-3.96M
34.79%-4.19M
-54.40%-4.11M
-695.81%-4.28M
Net Profit
62.89%-4.99M
54.13%-3.78M
-590.35%-15.74M
-262.66%-3.81M
-940.65%-13.44M
-647.12%-8.24M
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
46.04%-1.10M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
-29.59%-3.96M
30.61%-4.51M
-50.88%-4.11M
-554.30%-4.28M
Balance Sheet
Current assets
-21.71%15.00M
-49.04%8.43M
410.47%11.66M
304.42%14.70M
494.30%19.16M
297.18%16.54M
-56.50%2.28M
-30.24%3.64M
-50.55%3.22M
-50.23%4.17M
-51.66%5.25M
-42.34%5.21M
-48.04%6.52M
-46.95%8.37M
-46.00%10.86M
-61.96%9.04M
-55.61%12.55M
-49.87%15.78M
3489.96%20.11M
1859.95%23.76M
Total current liabilities
-0.77%2.56M
-3.69%3.06M
94.69%2.60M
276.98%1.89M
352.53%2.58M
785.89%3.18M
173.80%1.33M
-3.84%500.08K
3.79%570.08K
-65.63%358.55K
-70.17%487.14K
-72.60%520.03K
-70.74%549.29K
-18.22%1.04M
33.12%1.63M
109.40%1.90M
60.82%1.88M
-16.73%1.28M
-31.25%1.23M
-51.01%906.26K
Total assets
-1.83%95.21M
-4.39%90.17M
3929.02%91.99M
2559.39%96.69M
2907.64%96.98M
2164.06%94.31M
-56.50%2.28M
-30.24%3.64M
-50.55%3.22M
-50.23%4.17M
-51.66%5.25M
-42.34%5.21M
-48.04%6.52M
-46.95%8.37M
-46.00%10.86M
-61.96%9.04M
-55.61%12.55M
-49.87%15.78M
2460.21%20.11M
1767.53%23.76M
Total liabilities
2.45%14.58M
-49.13%15.27M
995.16%14.61M
2729.95%14.15M
2397.13%14.24M
8274.67%30.03M
173.80%1.33M
-3.84%500.08K
3.79%570.08K
-65.63%358.55K
-70.17%487.14K
-72.60%520.03K
-70.74%549.29K
-18.22%1.04M
33.12%1.63M
109.40%1.90M
60.82%1.88M
-16.73%1.28M
-79.33%1.23M
-87.65%906.26K
Total equity
-2.57%80.62M
16.51%74.90M
8050.68%77.39M
2532.19%82.54M
3017.28%82.75M
1588.54%64.28M
-80.06%949.43K
-33.17%3.14M
-55.55%2.65M
-48.04%3.81M
-48.38%4.76M
-34.31%4.69M
-44.05%5.97M
-49.48%7.33M
-51.14%9.22M
-68.75%7.14M
-60.63%10.67M
-51.57%14.50M
466.62%18.88M
476.98%22.86M
Cash Flow Statement
Net operating income
2.04%-4.59M
40.68%-3.64M
-259.59%-3.27M
-395.98%-4.03M
-399.52%-4.68M
-317.34%-6.13M
5.24%-910.14K
-9.34%-811.75K
44.81%-937.41K
45.00%-1.47M
61.32%-960.45K
79.70%-742.41K
36.05%-1.70M
48.41%-2.67M
6.25%-2.48M
-32.96%-3.66M
48.05%-2.66M
-126.48%-5.18M
-373.93%-2.65M
---2.75M
Net investment
----
-100.00%0.00
----
----
----
--3.76M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net financing
53.16%11.29M
-99.79%32.56K
100.00%0.00
-108.27%-120.13K
--7.37M
--15.32M
-106.07%-70.23K
--1.45M
----
100.00%0.00
-74.73%1.16M
----
--0.00
---86.00K
--4.58M
--0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00

FAQs

What are the current assets of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its current assets were 8.43M, with a year-on-year change of -49.04.

What are the total assets of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its total assets of Dogwood Therapeutics Inc were 90.17M, with a year-on-year change of -4.39.

What are the total liabilities of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its total liabilities of Dogwood Therapeutics Inc were 15.27M, with a year-on-year change of -49.13.

What is the total equity of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its total equity of Dogwood Therapeutics Inc was 74.90M, with a year-on-year change of 16.51.

What is the net operating income of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its net operating income of Dogwood Therapeutics Inc was -27.97M, with a year-on-year change of -128.74.

What is the net financing of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its net financing of Dogwood Therapeutics Inc was 7.28M, with a year-on-year change of -56.39.

What is the Earnings Per Share (EPS) of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -7.13, with a year-on-year change of 45.18.

What is the net income of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its net income was -35.51M, with a year-on-year change of -165.47.

What is the Return on Assets (ROA) of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.14, with a year-on-year change of -48.07.

What is the operating profit of Dogwood Therapeutics Inc?

According to Dogwood Therapeutics Inc's FY2025 earnings report, its operating profit was -27.97M, with a year-on-year change of -128.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy